Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders
NCT ID: NCT05566015
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-09-26
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate if a link between selfcompassion and treatment adherence exists in patients suffering from schizophrenic spectrum disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
NCT03471013
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse
NCT00798109
Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in Schizophrenia
NCT05464563
Diagnostic Announcement to Relatives of Patients With Schizophrenia
NCT04562961
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
self-administered questionnaires as well as clinical assessment of schizophrenia symptoms and depression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stabilized (PANNS score under 80)
* aged 18 or above
* In case of tutor or curator, agreement of this person is requiered
* psychiatrist who's following the patient agrees with the study
Exclusion Criteria
* non stabilized patient (PANSS score under 80 )
* patient suffering from toxic psychosis
* difficulties to understand french or cognitive impairment which are making it to difficult to answer the different self-administered questionnaires.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Crysalid center Clermont de l'Oise
UNKNOWN
CMP de Montataire
UNKNOWN
CMP de Chambly
UNKNOWN
CMP de Clermont de l'Oise
UNKNOWN
CMP de st Just en Chaussée
UNKNOWN
CMP de Senlis
UNKNOWN
CMP de Crepy en Valois
UNKNOWN
CMP de Pont St Maxence
UNKNOWN
CMP de Chantilly
UNKNOWN
CMP de Creil
UNKNOWN
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2019_843_0021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.